Literature DB >> 25759112

Molecular epidemiology of carbapenemase-producing Escherichia coli and the prevalence of ST131 subclone H30 in Shanghai, China.

F Zhang1, D Zhu, L Xie, X Guo, Y Ni, J Sun.   

Abstract

The molecular characteristics and epidemiology of carbapenemase-producing Escherichia coli (CPEC) isolates from Shanghai, China, were investigated using 21 imipenem-resistant E. coli isolates obtained from a Shanghai teaching hospital from 2011 to 2014. The presence of bla KPC, bla IMP, bla VIM, bla OXA-48, and bla NDM was assessed by polymerase chain reaction (PCR) amplification and sequencing. CPEC isolates were characterized by the Etest®, multilocus sequence typing (MLST), and pulse-field gel electrophoresis (PFGE). Plasmids carrying resistance genes were analyzed by conjugation experiments, replicon typing, plasmid MLST (pMLST), S1 nuclease PFGE (S1-PFGE), and Southern hybridization. The genetic environment of the resistance genes was determined by PCR and sequencing. Among the 21 E. coli isolates, 16 produced carbapenemases; of these, ten isolates transferred carbapenemase-encoding plasmids to recipient bacteria. Nine of the 16 isolates were clonally related, and their PFGE patterns were designated type A. ST131 was the predominant sequence type (11 isolates, 68.8 %); the H30 subclone comprised 81.8 % of the ST131 strains. In all three isolates, bla IMP-4 was located on 50-kb IncN plasmids. All but two bla KPC-2 genes were carried on IncF plasmids of various sizes. Hence, both clone-spread and horizontal transfer mediated the dissemination of carbapenemase-producing genes in the Shanghai isolates.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25759112     DOI: 10.1007/s10096-015-2356-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  19 in total

Review 1.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

2.  Identification of plasmids by PCR-based replicon typing.

Authors:  Alessandra Carattoli; Alessia Bertini; Laura Villa; Vincenzo Falbo; Katie L Hopkins; E John Threlfall
Journal:  J Microbiol Methods       Date:  2005-06-02       Impact factor: 2.363

3.  Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China.

Authors:  Ping Shen; Zeqing Wei; Yan Jiang; Xiaoxing Du; Shujuan Ji; Yunsong Yu; Lanjuan Li
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

4.  Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.

Authors:  Jia Chang Cai; Hong Wei Zhou; Rong Zhang; Gong-Xiang Chen
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

5.  Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China.

Authors:  Chuanming Zhang; Xiuyu Xu; Shuli Pu; Shifeng Huang; Jide Sun; Shuangshuang Yang; Liping Zhang
Journal:  Infect Genet Evol       Date:  2014-08-10       Impact factor: 3.342

6.  Isolation of the first IMP-4 metallo-β-lactamase producing Klebsiella pneumoniae in Tianjin, China.

Authors:  Jing Li; Zhidong Hu; Qiaojuan Hu
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

7.  Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.

Authors:  Yea-Yuan Chang; Yin-Ching Chuang; L Kristopher Siu; Tsu-Lan Wu; Jung-Chung Lin; Po-Liang Lu; Jann-Tay Wang; Lih-Shinn Wang; Yi-Tsung Lin; Ling-Ju Huang; Chang-Phone Fung
Journal:  J Microbiol Immunol Infect       Date:  2014-07-26       Impact factor: 4.399

8.  Novel genetic environment of the plasmid-mediated KPC-3 gene detected in Escherichia coli and Citrobacter freundii isolates from China.

Authors:  G Li; Q Wei; Y Wang; X Du; Y Zhao; X Jiang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-12-14       Impact factor: 3.267

9.  Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms.

Authors:  Makrina Totsika; Scott A Beatson; Sohinee Sarkar; Minh-Duy Phan; Nicola K Petty; Nathan Bachmann; Marek Szubert; Hanna E Sidjabat; David L Paterson; Mathew Upton; Mark A Schembri
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

10.  First identification of coexistence of blaNDM-1 and blaCMY-42 among Escherichia coli ST167 clinical isolates.

Authors:  Xueqing Zhang; Danping Lou; Yuanyuan Xu; Yongpeng Shang; Dan Li; Xiaoying Huang; Yuping Li; Longhua Hu; Liangxing Wang; Fangyou Yu
Journal:  BMC Microbiol       Date:  2013-12-05       Impact factor: 3.605

View more
  8 in total

Review 1.  The global epidemiology of carbapenemase-producing Enterobacteriaceae.

Authors:  David van Duin; Yohei Doi
Journal:  Virulence       Date:  2016-08-11       Impact factor: 5.882

2.  Common findings of bla CTX-M-55-encoding 104-139 kbp plasmids harbored by extended-spectrum β-lactamase-producing Escherichia coli in pork meat, wholesale market workers, and patients with urinary tract infection in Vietnam.

Authors:  T A V Hoang; T N H Nguyen; S Ueda; Q P Le; T T N Tran; T N D Nguyen; T V K Dao; M T Tran; T T T Le; T L Le; T Nakayama; I Hirai; T H Do; Q M Vien; Y Yamamoto
Journal:  Curr Microbiol       Date:  2016-12-09       Impact factor: 2.188

3.  Draft Genome Sequences of Two IMP-4-Producing Escherichia coli Sequence Type 131 Isolates in Australia.

Authors:  Hanna E Sidjabat; Jennifer Robson; David L Paterson
Journal:  Genome Announc       Date:  2015-08-27

4.  First Report of blaIMP-14 on a Plasmid Harboring Multiple Drug Resistance Genes in Escherichia coli Sequence Type 131.

Authors:  Nicole Stoesser; Anna E Sheppard; Gisele Peirano; Robert P Sebra; Tarah Lynch; Luke W Anson; Andrew Kasarskis; Mary R Motyl; Derrick W Crook; Johann D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

5.  Prevalence and characteristics of ST131 clone among unselected clinical Escherichia coli in a Chinese university hospital.

Authors:  Bin Li; Yanfang Lu; Fangjun Lan; Qingwen He; Chen Li; Yingping Cao
Journal:  Antimicrob Resist Infect Control       Date:  2017-11-15       Impact factor: 4.887

6.  Genomic characterization of an emerging blaKPC-2 carrying Enterobacteriaceae clinical isolates in Thailand.

Authors:  Anusak Kerdsin; Saowarat Deekae; Sunee Chayangsu; Rujirat Hatrongjit; Peechanika Chopjitt; Dan Takeuchi; Yukihiro Akeda; Kazunori Tomono; Shigeyuki Hamada
Journal:  Sci Rep       Date:  2019-12-06       Impact factor: 4.379

7.  Characteristics of diarrheagenic Escherichia coli among children under 5 years of age with acute diarrhea: a hospital based study.

Authors:  Yu Zhou; Xuhui Zhu; Hongyan Hou; Yanfang Lu; Jing Yu; Lie Mao; Liyan Mao; Ziyong Sun
Journal:  BMC Infect Dis       Date:  2018-02-01       Impact factor: 3.090

8.  Stepwise evolution and convergent recombination underlie the global dissemination of carbapenemase-producing Escherichia coli.

Authors:  Rafael Patiño-Navarrete; Isabelle Rosinski-Chupin; Nicolas Cabanel; Lauraine Gauthier; Julie Takissian; Jean-Yves Madec; Monzer Hamze; Remy A Bonnin; Thierry Naas; Philippe Glaser
Journal:  Genome Med       Date:  2020-01-20       Impact factor: 11.117

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.